Patients interested in retatrutide should speak to their GP or specialist and may search for recruiting trials via the NIHR 'Be Part of Research' portal
Enhanced well-being, marked by improved blood pressure, cholesterol, and blood sugar levels, accompanies this physical transformation
The three mechanisms of retatrutide: GLP-1 receptor agonism: Reduces appetite, improves glucose control, and slows gastric emptying
The higher dosage drives a more robust GH pulse, amplifying lipolysis in abdominal fat stores
Glutathione does not bleach the skin but may gradually support a brighter and more even skin tone
Further research is required to determine the optimal timing, tailoring, and potential risks of GLP-1RA treatment in BC patients